Femara 2.5 Mg 30Tab

Femara ingredients

Femara contains "letrozole", which helps increase estrogen levels by inhibiting the enzyme "aromatase", which reduces the synthesis of strogen, helping to treat estrogen-dependent breast cancer.

Femara uses

Femara 2.5 mg tablets are used for the treatment of estrogen-dependent breast cancer in the blood as follows:

• Adjuvant treatment for early hormone +ve breast cancer postmenopausal.

• extended adjuvant treatment for women with early breast cancer after menopause who have previously received tamoxifen for 5 years.

• A first-line treatment for advanced breast cancer which is hormone dependent.

• Treatment of advanced breast cancer relapse or progression of the disease for women who have artificially induced postmenopausal state, who have previously been treated by anti-estrogens.

• Dosage of Vimara tablets

• The appropriate dose of Vimara's tablets is determined by the doctor.

• The recommended dose per day is a tablet of 2.5 mg once per day.

Femara Side Effects

Femara may cause some side effects, such as:

• Hypercholesterolemia.

• Increase or low appetite.

• Depression.

• headache.

• dizziness.

• palpitations.

• Hot flushes.

• High blood pressure.

• Nausea and vomiting.

• excessive sweating.

• Joint pain.

• vaginal bleeding.

• Weight gain.

Femara contraindications

Femara is not used in the case of:

• Allergy to drug ingredients.

• Pregnancy and lactation.

Femara use precautions

The doctor should be consulted before using the medicine Femara, especially in the case of:

• osteoporosis, as the risk of developing it may increase.

• kidney disease.

• liver disease.

• Uncleraed menopausal status.

Drug interactions

The doctor should be consulted before taking Femarawith any other medication, especially:

• Antifungal.

• Antibiotics.

• Antiepileptic.

• Tamoxifen.

• Anticoagulants.